Literature DB >> 36268465

Precision medicine in cardiorenal and metabolic diseases with routinely collected clinical data: a novel insight.

Sheyu Li1, Qingyang Shi1, Valentyn Litvin2, Charles F Manski3.   

Abstract

Entities:  

Year:  2022        PMID： 36268465      PMCID： PMC9579962          DOI： 10.1093/pcmedi/pbac025

Source DB:  PubMed          Journal:  Precis Clin Med        ISSN： 2516-1571


× No keyword cloud information.
  10 in total

1.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal:  BMJ       Date:  2008-04-26

2.  Toward Credible Patient-centered Meta-analysis.

Authors:  Charles F Manski
Journal:  Epidemiology       Date:  2020-05       Impact factor: 4.822

3.  Warfarin pharmacogenetics: a rising tide for its clinical value.

Authors:  Julie A Johnson
Journal:  Circulation       Date:  2012-03-19       Impact factor: 29.690

4.  Embracing Uncertainty: The Value of Partial Identification in Public Health and Clinical Research.

Authors:  John Mullahy; Atheendar Venkataramani; Daniel L Millimet; Charles F Manski
Journal:  Am J Prev Med       Date:  2021-06-24       Impact factor: 5.043

Review 5.  Precision medicine in the management of type 2 diabetes.

Authors:  Anna L Gloyn; Daniel J Drucker
Journal:  Lancet Diabetes Endocrinol       Date:  2018-04-23       Impact factor: 32.069

6.  Data Sharing Statements for Clinical Trials - A Requirement of the International Committee of Medical Journal Editors.

Authors:  Darren B Taichman; Peush Sahni; Anja Pinborg; Larry Peiperl; Christine Laine; Astrid James; Sung-Tae Hong; Abraham Haileamlak; Laragh Gollogly; Fiona Godlee; Frank A Frizelle; Fernando Florenzano; Jeffrey M Drazen; Howard Bauchner; Christopher Baethge; Joyce Backus
Journal:  N Engl J Med       Date:  2017-06-05       Impact factor: 91.245

7.  Toward Causally Interpretable Meta-analysis: Transporting Inferences from Multiple Randomized Trials to a New Target Population.

Authors:  Issa J Dahabreh; Lucia C Petito; Sarah E Robertson; Miguel A Hernán; Jon A Steingrimsson
Journal:  Epidemiology       Date:  2020-05       Impact factor: 4.860

8.  Multilevel network meta-regression for population-adjusted treatment comparisons.

Authors:  David M Phillippo; Sofia Dias; A E Ades; Mark Belger; Alan Brnabic; Alexander Schacht; Daniel Saure; Zbigniew Kadziola; Nicky J Welton
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2020-06-07       Impact factor: 2.483

9.  Investigating the stratified efficacy and safety of pharmacological blood pressure-lowering: an overall protocol for individual patient-level data meta-analyses of over 300 000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists' Collaboration (BPLTTC).

Authors:  Kazem Rahimi; Dexter Canoy; Milad Nazarzadeh; Gholamreza Salimi-Khorshidi; Mark Woodward; Koon Teo; Barry R Davis; John Chalmers; Carl J Pepine
Journal:  BMJ Open       Date:  2019-05-22       Impact factor: 2.692

10.  A novel approach for identifying and addressing case-mix heterogeneity in individual participant data meta-analysis.

Authors:  Tat-Thang Vo; Raphael Porcher; Anna Chaimani; Stijn Vansteelandt
Journal:  Res Synth Methods       Date:  2019-12-02       Impact factor: 5.273
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.